Name: Ivette Suarrez Arroyo

Country: Puerto Rico

Affiliation:

Universidad Central del Caribe,
School of Medicine,
Puerto Rico,
United States.

Email: Send an Email


Address:

Department of Biochemistry,
Universidad Central del Caribe,
School of Medicine,
PO Box 60327 Bayamon,
PR 00960-6032.

Research Interests:

  • Breast cancer biology 
  • cancer molecular markers
  • Metastasis
  • EGFR trafficking.

Biography:

  • vette Suarez-Arroyo currently works at the Department of Biochemistry, Central University of the Caribbean. 
  • Ivette does research in Cancer Research, Cell Biology and Molecular Biology. 
  • Their most recent publication is 'medicines Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer.'

Research:

  • Medicines Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer.
  • The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease.
  • Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression.
  • Abstract B20: Combination of Ganoderma lucidum extract and erlotinib decreases IBC progression.
  • PO133 DIFFERENTIAL EXPRESSION OF PLASMA MEMBRANE PROTEINS IN INFLAMMATORY BREAST CANCER VIA STABLE ISOTOPE LABELED AMINO ACIDS IN CULTURE (SILAC).
  • Abstract 5556: Enhancing response of Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells.
  • Abstract 3219: Synergistic effect between Ganoderma lucidum (Reishi) and lapatinib in HER2+ inflammatory breast cancer cells.
  • Abstract 3212: Ganoderma lucidum (Reishi) chemosensitizes EGFR-overexpressing inflammatory breast cancer cells to erlotinib.
  • Abstract 2247: Ganoderma lucidum (Reishi) downregulates key proteins overexpressed in IBC and chemosensitizes EGFR-overexpressing cells to erlotinib.
  • Abstract 1672: Ganoderma lucidum (Reishi) induces autophagy in inflammatory breast cancer cells to promote cell death.
  • Anti-Tumor Effects of Ganoderma lucidum (Reishi) in Inflammatory Breast Cancer in In Vivo and In Vitro Models.
  • Abstract 1987: Ganoderma lucidum (Reishi) suppresses key protein synthesis initiation molecules in inflammatory breast cancer.
  • Abstract 1992: Ganoderma lucidum (Reishi) induces autophagy in inflammatory breast cancer by regulation of the mTOR signaling pathway.